Eliquis

ICER Reviews BMS' Eliquis, J&J's Xarelto Amidst Medicare Price Talks

ICER Reviews BMS’ Eliquis, J&J’s Xarelto Amidst Medicare Price Talks

Anika Sharma

As the United States embarks on a new era of drug price negotiations, the Institute for Clinical and Economic Review ...

Bristol Myers Squibb, R&D day, Inflation Reduction Act, Eliquis, BMS strategies

Bristol Myers Squibb aims for 25+ new indications to overcome patent losses and pricing challenges

Anika Sharma

Bristol Myers Squibb is placing a significant bet on its robust pipeline to weather challenges such as the Inflation Reduction ...

European Society of Cardiology, Bristol Myers Squibb, Pfizer, Anticoagulant, Eliquis, Rivaroxaban, Apixaban

Exploring Real-World Anticoagulant Transitions: Insights Unveiled at the European Society of Cardiology (ESC) Congress 2023

Anika Sharma

Amidst the vivid tapestry of medical advancements, a pivotal revelation has emerged from the collaborative efforts of the Bristol Myers ...